349 related articles for article (PubMed ID: 15040586)
1. The dark side of C5a in sepsis.
Ward PA
Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586
[TBL] [Abstract][Full Text] [Related]
2. A key role of C5a/C5aR activation for the development of sepsis.
Riedemann NC; Guo RF; Ward PA
J Leukoc Biol; 2003 Dec; 74(6):966-70. PubMed ID: 12960283
[TBL] [Abstract][Full Text] [Related]
3. Role of C5a-C5aR interaction in sepsis.
Guo RF; Riedemann NC; Ward PA
Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
[TBL] [Abstract][Full Text] [Related]
4. The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome.
Flierl MA; Schreiber H; Huber-Lang MS
J Invest Surg; 2006; 19(4):255-65. PubMed ID: 16835140
[TBL] [Abstract][Full Text] [Related]
5. Complement as a Major Inducer of Harmful Events in Infectious Sepsis.
Fattahi F; Zetoune FS; Ward PA
Shock; 2020 Nov; 54(5):595-605. PubMed ID: 32187106
[TBL] [Abstract][Full Text] [Related]
6. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
[TBL] [Abstract][Full Text] [Related]
7. A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a.
Schefold JC; von Haehling S; Corsepius M; Pohle C; Kruschke P; Zuckermann H; Volk HD; Reinke P
Shock; 2007 Oct; 28(4):418-25. PubMed ID: 17558345
[TBL] [Abstract][Full Text] [Related]
8. Anti-complement strategies in experimental sepsis.
Ward PA; Riedemann NC; Guo RF; Huber-Lang M; Sarma JV; Zetoune FS
Scand J Infect Dis; 2003; 35(9):601-3. PubMed ID: 14620141
[TBL] [Abstract][Full Text] [Related]
9. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
Nikiforovich GV; Marshall GR; Baranski TJ
Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of C5a-induced immunologic derangement in sepsis.
Xu R; Lin F; Bao C; Wang FS
Cell Mol Immunol; 2017 Sep; 14(9):792-793. PubMed ID: 28782758
[No Abstract] [Full Text] [Related]
11. Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement.
Sunyer JO; Boshra H; Li J
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):77-89. PubMed ID: 16112742
[TBL] [Abstract][Full Text] [Related]
12. [Complement activation and inflammation].
Abe M
Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
[TBL] [Abstract][Full Text] [Related]
13. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans.
Huber-Lang M; Sarma JV; Rittirsch D; Schreiber H; Weiss M; Flierl M; Younkin E; Schneider M; Suger-Wiedeck H; Gebhard F; McClintock SD; Neff T; Zetoune F; Bruckner U; Guo RF; Monk PN; Ward PA
J Immunol; 2005 Jan; 174(2):1104-10. PubMed ID: 15634936
[TBL] [Abstract][Full Text] [Related]
14. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
[TBL] [Abstract][Full Text] [Related]
15. Role of C5 activation products in sepsis.
Ward PA
ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
[TBL] [Abstract][Full Text] [Related]
16. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
[TBL] [Abstract][Full Text] [Related]
17. Role of C5a in inflammatory responses.
Guo RF; Ward PA
Annu Rev Immunol; 2005; 23():821-52. PubMed ID: 15771587
[TBL] [Abstract][Full Text] [Related]
18. Cancer exploiting complement: a clue or an exception?
Loveland BE; Cebon J
Nat Immunol; 2008 Nov; 9(11):1205-6. PubMed ID: 18936777
[No Abstract] [Full Text] [Related]
19. Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a.
Silawal S; Kohl B; Shi J; Schulze-Tanzil G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803624
[TBL] [Abstract][Full Text] [Related]
20. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
Thrane AS; Skehan JD; Thrane PS
Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
